Health Scope

Published by: Kowsar

The Necessity of Enhanced Harm Reduction Programs to Prevent Blood-Borne Infections Amongst Injection Drug Users

Mahmodreza Miri-Bonjar 1 , Alireza Khorram 1 , * and Alireza Ansari-Moghaddam 1
Authors Information
1 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • Health Scope: February 01, 2016, 5 (1); e32754
  • Published Online: February 15, 2016
  • Article Type: Editorial
  • Received: August 28, 2015
  • Accepted: September 22, 2015
  • DOI: 10.5812/jhealthscope.55868

To Cite: Miri-Bonjar M, Khorram A, Ansari-Moghaddam A. The Necessity of Enhanced Harm Reduction Programs to Prevent Blood-Borne Infections Amongst Injection Drug Users, Health Scope. 2016 ;5(1):e32754. doi: 10.5812/jhealthscope.55868.

Copyright © 2016, Health Promotion Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnote
References
  • 1. Saigi N, Espelt A, Folch C, Sarasa-Renedo A, Castellano Y, Majo X, et al. Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones. 2014; 26(1): 69-76[PubMed]
  • 2. Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One. 2014; 9(8)[DOI][PubMed]
  • 3. Philbin MM, FuJie Z. Exploring stakeholder perceptions of facilitators and barriers to using needle exchange programs in Yunnan Province, China. PLoS One. 2014; 9(2)[DOI][PubMed]
  • 4. Huang YF, Yang JY, Nelson KE, Kuo HS, Lew-Ting CY, Yang CH, et al. Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts. PLoS Med. 2014; 11(4)[DOI][PubMed]
  • 5. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med. 2014; 11(6)[DOI][PubMed]
  • 6. Wodak A, McLeod L. The role of harm reduction in controlling HIV among injecting drug users. Aids. 2008; 22 Suppl 2-92[DOI][PubMed]
  • 7. Edmonton AB. Working with people who use drugs: A harm reduction approach. Non Prescription Needle Use Initiativ. 2007;
  • 8. Barbeau A, Breton G, Lemieux B, Butterworth RF. Bilirubin metabolism - preliminary investigation. Can J Neurol Sci. 1976; 3(4): 365-72[PubMed]
  • 9. Thomson N. Harm reduction history, response, and current trends in Asia. J Food Drug Anal. 2013; 21(4)-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments